Related Experiment Video
Updated: Oct 18, 2025

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
491
Difficult to defeat obesity: An 8D approach
Sanjay Kalra1, Saurabh Arora2, Nitin Kapoor3
1Department of Endocrinology, Bharti Hospital, Karnal, India.
JPMA. the Journal of the Pakistan Medical Association
|September 28, 2021
Summary
This guide introduces an 8D approach to address difficult-to-treat obesity. It helps clinicians identify and overcome barriers to weight loss, improving patient outcomes.
Area of Science:
- Endocrinology
- Metabolism
- Clinical Medicine
Background:
- Obesity is a complex chronic disease with multifactorial causes.
- Many patients exhibit resistance or refractoriness to conventional weight loss strategies.
- Effective management requires a systematic approach to identify underlying issues.
Purpose of the Study:
- To present an 8D approach for evaluating and managing difficult-to-treat obesity.
- To provide a framework for identifying common causes of treatment resistance.
- To enhance the clinical practice of obesity care providers.
Main Methods:
- The 8D approach categorizes barriers into two domains: Approach and Analysis (evaluation), and Management and Monitoring.
- Specific 'D' factors include Dialogue, Definition, Diagnosis, Discipline, Drug, and Defective monitoring or 'Dead weight'.
- The framework is presented in a reader-friendly, pragmatic manner.
Main Results:
- The 8D approach systematically addresses potential causes of weight loss resistance.
- It facilitates a comprehensive evaluation of patient-specific challenges.
- The framework aids in tailoring management and monitoring strategies.
Conclusions:
- The 8D approach offers a practical tool for clinicians managing complex obesity cases.
- Identifying and addressing the '8Ds' can improve the effectiveness of weight loss interventions.
- This systematic evaluation is crucial for optimizing patient care and achieving desired outcomes.
Related Concept Videos
Obesity
719
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
719
Drug Dosing: Obese Patients
22
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
22
Binge Eating Disorders
218
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
218
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
27
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
27
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
24
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
24
Self-Discrepancy Theory
18.5K
One influential perspective on what motivates people's behavior is detailed in Tory Higgin's self-discrepancy theory (Higgins, 1987). He proposed that people hold disagreeing internal representations of themselves that lead to different emotional states.
18.5K

